Iovance Biotherapeutics, Inc.
Get Full AccessDescription
- Iovance Biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL). This approach, also known as adoptive T-cell therapy, was initially developed by Dr. Steven A. Rosenberg at the National Cancer Institute (NCI). In Phase 2 clinical trials conducted at the NCI, 56% and 24% of patients treated with this technology were reported by NCI to have achieved objective and complete response criteria, respectively.Our lead product candidate is an autologous, ready-to-infuse cell therapy, that has demonstrated distinctive efficacy in the treatment of metastatic melanoma.In addition to metastatic melanoma, carcinoma of the head and neck and cervical cancer our TIL therapy technology is potentially applicable to many other tumor types, including ovarian, breast, bladder, colorectal and other cancers. As we continue advancing our current clinical programs through the introduction of manufacturing and logistical efficiencies aimed at decreasing production time and optimizing distribution processes, we aim to establish TIL therapy as a revolutionary, accessible, mainline cancer therapy.
-
Headquarters:999 Skyway Road Suite 150, San Carlos, California, United States
More -
Phone Number: +1 650-260-7120
-
Website: https://www.iovance.com
-
Employees:215
-
Revenue:$250 - 500M
-
Legal Name:Iovance Biotherapeutics, Inc.
-
Iovance Biotherapeutics, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541715 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Iovance Biotherapeutics, Inc.
-
Where are Iovance Biotherapeutics, Inc.'s Headquarters?
Iovance Biotherapeutics, Inc.'s Headquarters are in 999 Skyway Road Suite 150,San Carlos,California,United States
-
What is Iovance Biotherapeutics, Inc.'s phone number?
Iovance Biotherapeutics, Inc.'s phone number is +1 650-260-7120
-
What is Iovance Biotherapeutics, Inc.'s official website?
Iovance Biotherapeutics, Inc.'s official website is https://www.iovance.com
-
What is Iovance Biotherapeutics, Inc.'s Revenue?
Iovance Biotherapeutics, Inc.'s revenue is $250 - 500M
-
What is Iovance Biotherapeutics, Inc.'s NAICS code?
Iovance Biotherapeutics, Inc.'s NAICS code is 541715
-
How many employees are working in Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. has 215 employees
-
What is Iovance Biotherapeutics, Inc.'s Industry?
Iovance Biotherapeutics, Inc. is in the industry of Biotechnology
-
Who is Iovance Biotherapeutics, Inc.'s CEO?
Iovance Biotherapeutics, Inc.'s CEO is Fred Vogt